NY A 9184
in committeeProvides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 9184 pass?
Not yet. NY A 9184 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO INSURANCE
What is NY A 9184 about?
Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers.
Who sponsors NY A 9184?
Jonathan Jacobson is the primary sponsor of NY A 9184, joined by 6 cosponsors.
Description
Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Jonathan Jacobsonprimary
- Paula Kaycosponsor
- Tommy Schiavonicosponsor
- Karines Reyescosponsor
- Angelo Santabarbaracosponsor
- Christopher Eachuscosponsor
- Jeffrey Dinowitzcosponsor
Committees
Not provided by source.
Action timeline
2025-10-17
REFERRED TO INSURANCE
referral-committee
2026-01-07
REFERRED TO INSURANCE
referral-committee
Versions
- A9184Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 9191
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 9184. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.